Characteristics | Total No. (%) | Enterococci infection | COR (95% CI) | P- value | |
---|---|---|---|---|---|
Presence No. (%) | Absence No. (%) | ||||
Total | 385 (100%) | 24 (6.2%) | 361 (93.8%) | ||
Sex | |||||
Female | 176 | 10 (5.7) | 166 (94.3) | 1.19 (0.51–2.75) | 0.68 |
Male | 209 | 14 (6.7) | 195 (93.3) | 1.00 | |
Age | 0.06 | ||||
<5 | 123 | 12 (9.8) | 111 (90.2) | 0.26 (0.03–2.10) | 0.21 |
5–14 | 36 | 1 (2.8) | 35 (97.2) | 0.26 (0.07–0.96) | 0.04 |
15–30 | 108 | 3 (2.8) | 105 (97.2) | 0.35 (0.10–1.27) | 0.11 |
31–50 | 83 | 3 (3.6) | 80 (96.4) | 1.54 (0.50–4.72) | 0.45 |
>50 | 35 | 5 (14.3) | 30 (85.7) | 1.00 | |
Hospital stay (hours) | |||||
<48 | 353 | 7 (2) | 346 (98) | 1.00 | |
≥48 | 32 | 17 (53) | 15 (47) | 56.02 (18.32–178.39) | 0.00 |
HIV | |||||
Negative | 367 | 22 (6) | 345 (94) | 1.00 | |
Positive | 18 | 2 (0.1) | 16 (99.9) | 1.96 (0.00–9.79) | 0.39 |
CD4 counta | |||||
<200 | 6 | 0 (0.0) | 6 (100) | 0.00 (0.00–9.76) | |
>200 | 12 | 2 (16.7) | 10 (83.3) | 1.00 | 0.52 |
HAARTa | |||||
Pre | 9 | 2 (22.2) | 7 (87.8) | 1.00 | |
On | 9 | 0 (0.0) | 9 (100) | 0.00 (0.00–4.38) | 0.47 |
WHO stagea | 1.00 | ||||
I | 5 | 2 (40) | 3 (60) | 1.00 | |
II | 1 | 0 (0.0) | 1 (100) | 0.00 (0.00–60.98) | 1.00 |
III | 6 | 0 (0.0) | 6 (100) | 0.00 (0.00–3.71) | 0.18 |
IV | 6 | 0 (0.0) | 6 (100) | 0.00 (0.00–3.71) | 0.18 |
History of: | |||||
Animal contact | 111 | 10 (9) | 101 (90) | 1.84 (0.73–4.58) | 0.15 |
Antibiotics usage | 54 | 14 (25.9) | 40 (74.1) | 11.24 (4.34–29.47) | 0.00 |
Cancer | 3 | 1 (33.3) | 2 (66.7) | 7.80 (0.00–116.25) | 0.18 |
Catheterization | 17 | 11 (64.7) | 6 (35.3) | 50.06 (14.24–184.31) | 0.00 |
Diabetics | 9 | 0 (0.0) | 9 (100) | 0.00 (0.00–9.28) | 1.00 |
Cotrimoxazole prophylaxisa | 36 | 2 (5.6) | 34 (94.4) | 0.87 (0.20 - 3.88) | 1.00 |
Hospitalization | 40 | 11 (27.5) | 29 (72.5) | 9.69 (3.66–25.68) | 0.00 |
Immunosuppressive usage | 51 | 3 (5.9) | 48 (94.1) | 0.93 (0.21–3.47) | 1.00 |
Laboratory confirmed Bacterial infection | 10 | 3 (30) | 7 (70) | 7.22 (1.36–34.43) | 0.02 |
Prosthetic device usage | 10 | 1 (10) | 9 (90) | 1.70 (0.21–14.01) | 0.48 |
Surgery | 6 | 0 (0.0) | 6 (100) | 0.00 (0.00–14.88) | 1.00 |
UTI | 55 | 2 (3.6) | 53 (96.4) | 0.53 (0.08–2.42) | 0.55 |